Cyclica, Genome Institute of Singapore sign drug discovery partnership
Canadian biotech company Cyclica has signed a multi-year and multi-project drug discovery partnership with the Genome Institute of Singapore (GIS) in oncology and related diseases. ... Read More
Yuhan Pharmaceuticals to use Cyclica’s AI-driven drug discovery platform
Yuhan Pharmaceuticals has entered into a collaboration with Canadian biotechnology company Cyclica to use the latter's artificial intelligence (AI) driven integrated drug discovery platform in ... Read More